Pulmonary hypertension and pregnancy

International Journal of Obstetric Anesthesia

Volumn 18, Issue 2, 2009, Pages 156-164

  Madden, B P ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Plexogenic pulmonary arteriopathy; Pregnancy; Pulmonary hypertension; Pulmonary vasoactive compounds

Indexed keywords

DELIVERY; HIGH RISK PATIENT; HIGH RISK PREGNANCY; HUMAN; OBSTETRIC ANESTHESIA; PATIENT MONITORING; PREGNANCY; PREGNANT WOMAN; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW;

ADULT; ANESTHESIA, OBSTETRICAL; ANTIHYPERTENSIVE AGENTS; DELIVERY, OBSTETRIC; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PROGNOSIS; YOUNG ADULT;

EID: 62149129343     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijoa.2008.10.006     Document Type: Review

References (48)

1. Wagenvoort C.A., and Wagenvoort H. Primary pulmonary hypertension: a path pathologic study of the lung vessels in 156 classically diagnosed cases. Circulation 42 (1970) 1163-1184
2. Madden B., Gosney J., Coghlan J., et al. Pre-transplant clinicopathological correlation in end-stage primary pulmonary hypertension. Eur Respir J 7 (1994) 672-678
3. Thompson J.R., Machado R.D., Pauciulo M.W., et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BPMR-11, a receptor member of the TGF-β family. J Med Genet 37 (2000) 741-745
4. D'Alonzo G.E., Barst R.J., Ayres S.M., et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 115 (1991) 343-349
5. Rubin L J; American College of Chest Physicians. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence based clinical practice guidelines. Chest 2004; 126: S1-S92.
6. Miyamoto S., Nagaya N., Satoh T., et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 161 (2000) 487-492
7. Ueland K. Maternal cardiovascular dynamics. VII. Intrapartum blood volume changes. Am J Obstet Gynecol 126 (1976) 671-677
8. Pritchard J. Changes in the blood volume during pregnancy and delivery. Anesthesiology 26 (1965) 393-399
9. Lund C., and Donovan J. Blood volume during pregnancy. Significance of plasma and red cell volumes. Am J Obstet Gynecol 98 (1967) 394-403
10. Foley M. Maternal cardiovascular adaptation to pregnancy. In: Rose B, ed. UpToDate, vol 13.2, Wellesley: MA; 2005.
11. Robson S., Hunter S., Boys R., Dunlop W., and Bryson M. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 256 (1989) H1060-H1065
12. Capeless E., and Clapp J. Cardiovascular changes in early phase of pregnancy. Am J Obstet Gynecol 161 (1989) 1449-1453
13. Duvekot J., and Peeters L. Maternal cardiovascular hemodynamic adaptations to pregnancy. Obstet Gynecol Surv 49 (1994) S1-S14
14. McCaffrey R., and Dunn L. Primary pulmonary hypertension in pregnancy. Obstet Gynecol Surv 19 (1964) 567-591
15. Clapp III J.F., and Capeless E. Cardiovascular function before, during and after the first and subsequent pregnancies. Am J Cardiol 80 (1997) 1469-1473
16. Pechet L., and Alexander B. Clotting factors in pregnancy. N Engl J Med 265 (1961) 1093-1097
17. Walker M., Garner P., Keely E., et al. Changes in activated protein C resistance during normal pregnancy. Am J Obstet Gynecol 177 (1997) 162-169
18. Hellgren M., and Blomback M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal conditions. Gynecol Obstet Invest 2 (1981) 141-154
19. Weiss B., Zemp L., Seifert B., and Hess O.M. Outcome of pulmonary vascular disease in pregnancy: A systemic overview from 1978 through 1996. J Am Coll Cardiol 31 (1998) 1650-1657
20. Daliento L., Somerville J., Presbitero P., et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 19 (1998) 1845-1855
21. Jaigobin C., and Silver F. Stroke and pregnancy. Stroke 31 (2000) 2948-2951
22. McPhedran P. Venous thromboembolism during pregnancy. In: Burrow G, Duffy T, Copel J, eds. Medical complications during pregnancy. Philadelphia: Elsevier Saunders; 2004: 87-102.
23. Gleicher N., Midwall J., and Hochberger D. Eisennmenger's syndrome and pregnancy. Obstet Gynecol 34 (1979) 721-741
24. Weiss B., and Hess O. Pulmonary vascular disease and pregnancy: Current controversies, management strategies and perspectives. Eur Heart J 21 (2000) 104-115
25. Satoh H., Masuda Y., Izuta S., Yaku H., and Obara H. Pregnant patient with primary pulmonary hypertension: general anesthesia and extracorporeal membrane oxygenation support for termination of pregnancy. Anesthesiology 97 (2002) 1638-1640
26. Clouthier D., Williams S., Hammer R., Richardson J.A., and Yanagisawa M. Cell-autonomous and nonautonomous actions of endothelin-A receptor signalling in craniofacial and cardiovascular development. Dev Biol 261 (2003) 506-519
27. Warnes C. Pregnancy and pulmonary hypertension. Int J Cardiol 97 (2004) 11-13
28. Al-Mobeireek A., Almutawa J., and Alsatli R. The nineteenth pregnancy in a patient with cor pulmonale and severe pulmonary hypertension: a management challenge. Acta Obstet Gynecol Scand 82 (2003) 676-678
29. ACOG (Committee Opinion). Safety of Lovenox in pregnancy. Obstet Gynecol 2002; 100: 845-6.
30. Bates S., Greer I., Hirsh J., and Ginsberg J.S. Use of antithrombotic agents in pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 3 Suppl (2004) 627S-644S
31. MacLean M.R. Endothelin-1: a mediator of pulmonary hypertension?. Pulm Pharmacol Ther 11 (1998) 125-132
32. Benigni A., and Remuzzi G. Endothelin antagonists. Lancet 353 (1999) 133-138
33. Channick R.N., Simonneau G., Sitbon O., et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo controlled study. Lancet 358 (2001) 1119-1123
34. Barst R.J., Langleben D., Frost A., et al. Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med 169 (2004) 441-447
35. Madden B.P., Allenby M., Loke T.K., and Sheth A. A potential role for sildenafil in the management of pulmonary hypertension associated with parenchymal lung disease. Vasc Pharmacol 44 (2006) 372-376
36. Madden B.P., Sheth A., Ho T., and Kanagasabay R. A potential role for sildenafil in the management of perioperative pulmonary hypertension and right ventricular dysfunction following cardiac surgery. Br J Anaesth 93 (2004) 155-156
37. Sheth A., Park J.S., Ong Y.E., Ho T., and Madden B.P. Early haemodynamic benefit of sildenafil in patients with co-existing chronic thromboembolic pulmonary hypertension and left ventricular dysfunction. Vasc Pharmacol 42 (2005) 41-45
38. Madden B.P., Sheth A., Wilde M., and Ong Y.E. Does sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?. Vasc Pharmacol 47 (2007) 184-188
39. La Cassie H., Germain A., Valdes G., Fernández M.S., Allamand F., and López H. Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Obstet Gynecol 103 (2004) 1118-1120
40. Easterling T., Ralph D., and Schmucker B. Pulmonary hypertension in pregnancy: Treatment with pulmonary vasodilators. Obstet Gynecol 93 (1999) 494-498
41. Stewart R., Tuazon D., Olson G., and Duarte A.G. Pregnancy and primary pulmonary hypertension: Successful outcome with epoprostenol therapy. Chest 119 (2001) 973-975
42. Lam G.K., Stafford R.E., Thorp J., Moise K.J., and Cairns B.A. Inhaled nitric oxide for primary pulmonary hypertension in pregnancy. Obstet Gynecol 98 (2001) 895-898
43. Decoene C., Bourzoufi K., Moreau D., Narducci F., Crepin F., and Krivosic-Horber R. Use of inhaled nitric oxide for emergency Cesarean section in a woman with unexpected primary pulmonary hypertension. Can J Anaesth 48 (2001) 584-587
44. McDonnell N.J., Chan B.O., and Frengley R.W. Rapid reversal of critical haemodynamic compromise with nitric oxide in a parturient with amniotic fluid embolism. Int J Obstet Anesth 16 (2007) 269-273
45. Nihill M.R., O'Laughlin M.R., and Mullins C.E. Effects of atrial septostomy in patients with terminal cor pulmonale due to pulmonary vascular disease. Cathet Cardiovasc Diagn 24 (1991) 166-172
46. Smedstad K.G., Cramb R., and Morison D.H. Pulmonary hypertension and pregnancy: A series of eight cases. Can J Anaesth 41 (1994) 502-512
47. Vongpatanasin W., Brickner M., Hillis L., and Lange R.A. The Eisenmenger syndrome in adults. Am Intern Med 128 (1998) 745-755
48. Mushlin P, Davidson K. Cardiovascular disease during pregnancy. In: Datta S, ed. Anesthetic and obstetric management of high-risk pregnancy. New York: Springer; 1996.